Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord
Stem Cell Reviews and Reports · 2024
DOI: 10.1007/s12015-024-10712-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von Charlotte Carcopino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université de Paris Cité, INSERM, Innovative Therapies in Hemostasis, F-75006, Paris, France. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Umbilical Cord, Neovascularization, Physiologic, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: AP-HP, Université Paris Descartes, Inserm.
Abstract (Originalsprache)
Addressing the challenges in managing ischemic tissue repair and remodelling remains a prominent clinical concern. Current research is heavily concentrated on identifying innovative cell-based therapies with the potential to enhance revascularization in patients affected by these diseases. We have previously developed and validated a manufacturing process for human umbilical cord mesenchymal stromal cells (UC-MSCs)-based cell therapy medicinal product, according to Good Manufacturing Practices. In this study, we demonstrate that these UC-MSCs enhance the proliferation and migration of endothelial cells and the formation of capillary structures. Moreover, UC-MSCs and endothelial cells interact, allowing UC-MSCs to acquire a perivascular cell phenotype and consequently provide direct support to the newly formed vascular network. This characterization of the proangiogenic properties of this UC-MSCs based-cell therapy medicinal product is an essential step for its therapeutic assessment in the clinical context of vascular regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université de Paris Cité, INSERM, Innovative Therapies in Hemostasis, F-75006, Paris, France.
- Centre d'Investigation Clinique en Biothérapies CBT501, INSERM, F-75010, Paris, France.
- Cell therapy Department, AP-HP, Saint Louis Hospital, F-75010, Paris, France.
- Université de Paris Cité, INSERM, U976, F-75010, Paris, France.
- Hematology Department, AP-HP, Georges Pompidou European Hospital, 20 rue Leblanc, F-75015, Paris, France.
- Université de Paris Cité, INSERM, Innovative Therapies in Hemostasis, F-75006, Paris, France. david.smadja@me.com.
ORCID-Profile: David M Smadja
Förderung
- AP-HP
- Université Paris Descartes
- Inserm
Zitieren
APA
Carcopino, C., Rossi, E., Mebarki, M., El Hamaoui, D., Gaussem, P., Larghero, J., Smadja, D. M., & Cras, A. (2024). Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10712-8
Vancouver
Carcopino C, Rossi E, Mebarki M, El Hamaoui D, Gaussem P, Larghero J, et al. Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10712-8
BibTeX
@article{Carcopino2024,
author = {Carcopino, Charlotte and Rossi, Elisa and Mebarki, Miryam and El Hamaoui, Divina and Gaussem, Pascale and Larghero, Jérôme and Smadja, David M and Cras, Audrey},
title = {Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord},
journal = {Stem Cell Reviews and Reports},
year = {2024},
doi = {10.1007/s12015-024-10712-8}
}
EUVIMED